Clinical Trial Update: Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating zoledronic acid added to combination chemotherapy for newly diagnosed metastatic osteosarcoma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Combination chemotherapy
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Children's Oncology Group | Conditions: Sarcoma | Phase 1 | Status: COMPLETED | Results posted: 2014-07-04